August 14, 2017 (Shareholders Foundation) - An investigation on behalf of investors of DENTSPLY SIRONA Inc (NASDAQ:XRAY) shares over potential securities laws violations by DENTSPLY SIRONA and certain of its directors and officers in connection with certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of DENTSPLY SIRONA Inc (NASDAQ:XRAY) concerning whether a series of statements by DENTSPLY SIRONA regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

York, PA based DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. DENTSPLY SIRONA Inc reported that its annual Total Revenue rose from over $2.67 billion in 2015 to over $3.74 billion in 2016 and that its Net Income increased from $251.20 million in 2015 to $429.90 million in 2016.

Shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) grew from $45.30 per share in late 2014 to as high as $65.40 per share.

On August 9, 2017, DENTSPLY SIRONA Inc disclosed second quarter 2017 earnings that fell below expectations, as well as an SEC investigation concerning the Companys accounting and disclosures, including its accounting and disclosures relating to transactions with a significant distributor of the Company.

Shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) declined to as low as $54.04 per share on August 14, 2017.